The value of continuous ST segment monitoring in patients with unstable angina

European Heart Journal

Volumn 22, Issue 21, 2001, Pages 1972-1973

  Cohn, P F ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRIC ACID DERIVATIVE;

BYPASS SURGERY; CARDIOVASCULAR RISK; CLINICAL TRIAL; EDITORIAL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT; ST SEGMENT DEPRESSION; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; ELECTROCARDIOGRAPHY, AMBULATORY; HUMANS; MYOCARDIAL ISCHEMIA; PROGNOSIS;

EID: 0035182683     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.2827     Document Type: Editorial

References (10)

1. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina
2. Silent ischemia predicts infarction and death during 2 year follow-up of unstable angina
3. Prognostic significance of silent myocardial ishcemia in patients with unstable angina
4. Prognostic implications of transient, predominantly silent-ischemia in patients with unstable angina pectoris
5. Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events. Meta-analysis of three studies involving 995 patients
6. Why is recurrent myocardial ischemia a predictor of adverse outcome is unstable angina? An observational study of myocardial ischaemia and its relation to coronary anatomy
7. Reduction of transient myocardial ischemia with pravastatin in addition to conventional treatment in patients with angina pectoris
8. Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease
9. Asymptomatic cardiac ischemia pilot (ACIP) study. Two-year follow-up